ADIPOQ and breast carcinoma: Peripheral adiponectin concentrations above the mean/median were associated with lower breast cancer specific mortality (BCM)21, better disease-free survival23,24, and lower recurrence in ER negative breast cancer only19, whereas expression in triple negative breast cancer was not associated with survival30.